Jove
Visualize
Contact Us

Related Experiment Videos

Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates.

Jillian G Baker1, Stephen J Hill

  • 1Institute of Cell Signalling, Medical School, Nottingham, NG7 2UH, UK.

Trends in Pharmacological Sciences
|July 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabinoid CB<sub>2</sub> receptor drives trastuzumab resistance and predicts durable anti-HER2 response.

Oncogene·2026
Same author

Homozygosity for rare or common hypomorphic <i>IL23R</i> variants confers a predisposition to tuberculosis in humans.

bioRxiv : the preprint server for biology·2026
Same author

Two-Step Ligand-Directed Covalent Fluorescent Labeling of the Adenosine A<sub>1</sub>-Receptor That Maintains Its Orthosteric Binding Site's Availability to Bind Ligands.

Journal of medicinal chemistry·2026
Same author

Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-Blocker.

Pharmacology research & perspectives·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025
Same author

Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor.

Molecular pharmacology·2025
Same journal

Engineering cells for solid tumor therapy.

Trends in pharmacological sciences·2026
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Antagonist affinity measurements are not always constant. New evidence shows cell-surface receptors can exhibit varying antagonist affinities due to factors like allosterism and signaling pathway differences.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cell Biology

Background:

  • Antagonist affinity is traditionally used to characterize cell-surface receptors.
  • It was assumed antagonist affinity is constant for a given receptor-antagonist interaction.
  • Changes in antagonist affinity were considered evidence for novel receptor subtypes.

Purpose of the Study:

  • To discuss mechanisms causing variable antagonist affinity for the same receptor.
  • To challenge the traditional assumption of constant antagonist affinity.
  • To highlight the impact of experimental conditions on receptor pharmacology.

Main Methods:

  • Literature review and theoretical discussion of receptor-ligand interactions.
  • Analysis of emerging evidence on receptor binding sites and allosterism.

Related Experiment Videos

  • Exploration of G protein coupling and signal pathway-dependent pharmacology.

    • Main Results:

    • Receptors can possess multiple binding sites.
    • The same receptor can exhibit different antagonist affinities under distinct experimental conditions.
    • Mechanisms include allosterism, differential G protein coupling, multiple receptor sites, and signal-pathway-dependent pharmacology.

    Conclusions:

    • Antagonist affinity is not a fixed property and can vary.
    • Variable antagonist affinity provides insights into complex receptor behavior.
    • Understanding these mechanisms is crucial for accurate receptor characterization and drug development.